FdaApplication

ANDA 209720

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS CO GMBH
application_typeANDA
approval_date2018-03-09

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL

2 products